Highly diffuse recurrence pattern after anti-angiogenic therapy with bevacizumab

M. Westphal, O. Heese, J. Panse & F. Förster
Objective: To describe the unique pattern of recurrent glioblastoma after treatment with an antibody against the vascular endothelial growth factor (bevacizumab), which is a very effective anti-angiogenic treatment. Methods: The institutional series were reviewed for patients, who failed after the[for full text, please go to the a.m. URL]